Corneal edema after aqueous drainage device implantation.
Wells
Anthony P
AP
Ophthalmology Unit, Wellington School of Medicine, Wellington, New Zealand. Jessica.binns@wolterskluwer.com
Barton
Keith
K
Konstas
Anastasios G P
AG
D000368:Aged; D000959:Antihypertensive Agents / Q000627:therapeutic use; D015715:Corneal Edema / Q000209:etiology*; D004359:Drug Therapy, Combination; D017889:Exfoliation Syndrome / Q000601:surgery; D005260:Female; D005901:Glaucoma / Q000601:surgery; D020327:Glaucoma Drainage Implants / Q000009:adverse effects*; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects; D000077338:Latanoprost; D011461:Prostaglandins F, Synthetic / Q000627:therapeutic use; D013449:Sulfonamides / Q000627:therapeutic use; D013876:Thiophenes / Q000627:therapeutic use; D014065:Tonometry, Ocular; D014792:Visual Acuity
D000959:Antihypertensive Agents; D011461:Prostaglandins F, Synthetic; D013449:Sulfonamides; D013876:Thiophenes; D000077338:Latanoprost; C062765:dorzolamide